通过mTOR对HOXB13的层次酸化决定了其在前列腺癌中的活性和瘤功能
Yonghong Chen1,2, Catherine R Dufour1, Lingwei Han1,2
1Goodman Cancer Institute, McGill University, Montréal, Québec, Canada.
Molecular cancer research : MCR
|July 6, 2023
概括
哺乳动物的目标拉巴胺素 (mTOR) 直接化HOXB13,增强其致癌性质并促进前列腺癌的生长. 这种酸化会产生独特的基因特征,有助于区分前列腺癌的不同阶段.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 拉巴胺素 (mTOR) 信号传导的哺乳动物目标失调是前列腺癌进展的关键驱动因素.
- 转录因子HOXB13影响雄激素反应和前列腺癌的发展.
- 最近的一项发现表明,HOXB13与mTOR在染色质上形成复合体,这表明存在功能联系.
研究的目的:
- 为了阐明前列腺癌中HOXB13和mTOR之间的功能交叉.
- 研究mTOR如何影响HOXB13活性和瘤潜在的机制.
主要方法:
- 通过mTOR.研究了HOXB13的直接相互作用和等级酸化.
- 利用相仿性突变来评估酸化的功能影响.
- 进行了体外和体内 (小鼠外移植) 研究,以评估前列腺癌细胞生长.
- 进行了转录分析,以确定HOXB13依赖基因特征.
主要成果:
- mTOR在特定的部位 (Thr8,Thr41,Ser31) 直接酸化HOXB13.
- 酸化促进HOXB13与E3结合酶SKP2的相互作用,增强其致癌性质.
- 突变HOXB13具有相仿突变,在体外和体内加速前列腺癌的生长.
- 一个依赖-HOXB13的基因特征有效地区分了正常,原发性和转移性前列腺癌组织.
结论:
- mTOR直接酸化HOXB13,建立一个驱动前列腺癌的分子级联.
- -HOXB13决定了一个特定的基因程序,具有显著的致癌影响.
- 通过mTOR向HOXB13酸化代表了晚期前列腺癌的潜在治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K


